Expertise in
8
conditions

Yoshitaka Honma

Department Of Head And Neck, 
JP 
Expertise in
8
conditions
Department Of Head And Neck, 
JP 

Overview

Yoshitaka Honma practices practicing medicine in Japan.

Mr. Honma is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Esophageal Cancer, Stomach Cancer, PIK3CA-Related Overgrowth Spectrum, Laryngectomy, and Endoscopy.

He is actively involved in clinical research, co-authoring 157 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Department Of Head And Neck, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-Blind, Adaptive, Phase II/III Study of GSK3359609 in Combination With Pembrolizumab and 5FU-Platinum Chemotherapy Versus Placebo in Combination With Pembrolizumab Plus 5FU-Platinum Chemotherapy for First-Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
A Randomized, Double-Blind, Adaptive, Phase II/III Study of GSK3359609 in Combination With Pembrolizumab and 5FU-Platinum Chemotherapy Versus Placebo in Combination With Pembrolizumab Plus 5FU-Platinum Chemotherapy for First-Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Enrollment Status: Terminated
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drugs: Feladilimab, Pembrolizumab, Fluorouracil, Cisplatin, Carboplatin
Study Phase: Phase 3

157 Total Publications

A multicenter randomized phase III trial to evaluate the value of omission of elective neck dissection for T3-T4aN0 laryngeal cancer: JCOG2407 (JALNECK).
A multicenter randomized phase III trial to evaluate the value of omission of elective neck dissection for T3-T4aN0 laryngeal cancer: JCOG2407 (JALNECK).
Journal: Japanese journal of clinical oncology
Published: May 17, 2026

Frequently Asked Questions about Yoshitaka Honma

Is Yoshitaka Honma a top-rated expert for Esophageal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Yoshitaka Honma is classified as an Elite expert for Esophageal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Yoshitaka Honma participate in research or clinical trials?

Yes. Yoshitaka Honma has published 157 articles and abstracts on conditions like Esophageal Cancer. You can view a list of Yoshitaka Honma's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Honma's expertise for a condition
ConditionClose
View All 23 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile